Pharmacoproteomics: Advancing the efficacy and safety of regenerative therapeutics

D. K. Arrell, N. J. Niederländer, C. Perez-Terzic, S. Chung, A. Behfar, A. Terzic

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Proteomic analyses encompass a suite of high-throughput technologies for large-scale separation and identification of proteins responsible for execution of physiological processes. As such, proteomics is ideally suited to dissecting developmental complexity and dynamics, an understanding of which is vital to the realization of regenerative therapeutic medicine. Pharmacoproteomics is increasingly targeting characterization of regenerative therapeutic strategies. A perspective on the application of proteomics to further our understanding of cardiac regenerative medicine, in concert with guided cardiogenic programming, is delineated herein.

Original languageEnglish (US)
Pages (from-to)316-319
Number of pages4
JournalClinical pharmacology and therapeutics
Issue number3
StatePublished - Sep 1 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pharmacoproteomics: Advancing the efficacy and safety of regenerative therapeutics'. Together they form a unique fingerprint.

Cite this